Virginia Borges, MD

University of Colorado Anschutz

IN PARTNERSHIP WITH

OVERVIEW

OncLive^® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.

Registration for this Summit is complimentary.

TOPICS INCLUDE: 

• Treatment Selection for High Risk ER+ HER2-Negative Breast Cancer in the Early-Stage Setting
• Evolving Frontline Treatment Strategies in HR+ Breast Cancer
• Treatment Strategies for Sequencing Beyond Frontline CDK4/6i + ET in Metastatic Breast Cancer
• Reshaping HR+ and TNBC: Antibody-Drug Conjugates (ADC)
• Top Insights for HER2+ Breast Cancer
  
• Real World Oncology: Translating Data to Clinical Practice
• Live Q&A

OncLive - an MJH Life Sciences brand

Copyright 2025 (C) Intellisphere, LLC

259 Prospect Plains Rd, Bldg H

Monroe, NJ 08831

Terms & Conditions | Privacy Policy